Fayazfar Setareh, Arefi Oskouie Afsaneh, Safaei Akram, Zali Hakimeh, Nazemalhosseini Mojarad Ehsan
Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S41-S50.
The present study aimed to detect key candidate genes and pathways involved in colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.
Although colorectal cancer (CRC) is the third most common type of cancer, the involved signaling pathways and driver-genes remain largely unclear. CRC begins with the malignant transformation of precancerous lesions including aberrant crypt foci (ACF) and benign adenomatous polyp or adenoma.
A list of formerly reported ACF, adenoma, and CRC-associated proteins was obtained from GeneCards, and then the data in online David Bioinformatics Resources was analyzed. The protein-protein interactions were surveyed utilizing String database and Cytoscape software. After hubs and bottlenecks were recognized, the key genes and pathways were identified through different bioinformatics analysis.
The most important pathways associated with colorectal aberrant crypt foci-to-adenoma progression were attributed to "pathways in cancer" and "chemokine signaling pathway" and those in adenoma-to-carcinoma progression were related to "pathways in cancer," "chemokine signaling pathway," and "Ras signaling pathway." The genes participating in these pathways are key ones. Furthermore, PRKACB, CUL2, and GSK3B were significant as the seed in the clusters related to adenoma and GNB1, RALBP1, ROCK1, and IKBKG in the clusters related to cancer.
The key candidate genes and pathways in progress CRC formed precursor lesions were identified by integrated bioinformatics analysis. The results could lead to a better understanding of the cause and underlying molecular events as well as detection of therapeutic targets for CRC.
本研究旨在检测参与结直肠癌异常隐窝灶-腺瘤-癌进展过程的关键候选基因和信号通路。
尽管结直肠癌(CRC)是第三大常见癌症类型,但其中涉及的信号通路和驱动基因仍不清楚。结直肠癌始于癌前病变的恶性转化,包括异常隐窝灶(ACF)和良性腺瘤性息肉或腺瘤。
从基因卡片(GeneCards)获取先前报道的与ACF、腺瘤和CRC相关的蛋白质列表,然后分析在线大卫生物信息学资源(David Bioinformatics Resources)中的数据。利用String数据库和Cytoscape软件研究蛋白质-蛋白质相互作用。识别出枢纽和瓶颈后,通过不同的生物信息学分析确定关键基因和信号通路。
与结直肠癌异常隐窝灶-腺瘤进展相关的最重要信号通路为“癌症中的信号通路”和“趋化因子信号通路”,而与腺瘤-癌进展相关的通路则与“癌症中的信号通路”、“趋化因子信号通路”和“Ras信号通路”有关。参与这些通路的基因是关键基因。此外,PRKACB、CUL2和GSK3B在与腺瘤相关的簇中作为种子基因具有重要意义,而GNB1、RALBP1、ROCK1和IKBKG在与癌症相关的簇中具有重要意义。
通过综合生物信息学分析确定了结直肠癌进展过程中形成前体病变的关键候选基因和信号通路。这些结果有助于更好地理解结直肠癌的病因和潜在分子事件,以及检测结直肠癌的治疗靶点。